Novaptech à la pointe des biocapteurs basés sur les aptamères : conférences à venir cet automne
This September, Novaptech will share its latest advances in aptamer-based biosensing at two major international events. Our teams will present how NOVAptamers and our proprietary NOVAswitch technology are opening new avenues for diagnostics, from animal health to neurodegenerative diseases. 📍 2nd International Conference on Infectious Diseases – Vienna, Austria (September 25–26, 2025)Dr Jean-Jacques Toulmé, Chief Scientific Officer at Novaptech, will highlight the use of novel NOVAptamers for the detection of animal viruses, with a special focus on innovative approaches for air sample analysis. This technology holds significant promise for biosecurity applications and early outbreak detection. 📍 Satellite Workshop “Low-Dimensional Materials for Neuroscience and Biomedicine” – NanoBalkan 2025, Tirana (October 1, 2025)Dr Sandeep Kumar, Research Engineer at Novaptech, will present the development of aptamers targeting early biomarkers of Alzheimer’s disease. These cutting-edge molecules could pave the way for earlier, less invasive diagnostic tools in neurodegenerative research. These two events represent a unique opportunity to discover how NOVAptamers can be applied to real-world challenges in infectious diseases, neuroscience, and biosensing. 👉 If you would like to connect with Dr Jean-Jacques Toulmé or Dr Sandeep Kumar during these events, please reach out via contact@novaptech.com or on LinkedIn. 👉 Can’t attend? Learn more about NOVAptamer applications here: Contact us. ✨ These research programs are carried out with the financial support of the European Union.
Découvrez les NOVAptamers : des aptamères hautement spécifiques pour vos projets
Our R&D team is proud to introduce NOVAptamers – a range of aptamers developed and optimized by Novaptech – designed against a wide variety of targets, including proteins, peptides and small molecules. 🧬 Browse our NOVAptamers collection today and find the one that fits your needs! Test them today in your lab – whether you’re working in fundamental research, diagnostics, or biotechnology – NOVAptamers are the solution to accelerate your developments. Customizable with various functional groups, they integrate easily into your assay or device. New NOVAptamers targeting small molecules, pesticides, antibiotics, and peptides will be added soon. Stay connected!! Feel free to contact us for advice and for a personalized offer or pricing information. Explore our solutions now!
Novaptech aux Rencontres Biacore™ 2025 à Lyon – 25 juin
We’re pleased to announce that Novaptech will participate in the French Biacore™ User Meeting, organized by Cytiva. Dr. Petra Ivaskovic, SPR (Surface Plasmon Resonance) and BLI (BioLayer Interferometry) specialist at Novaptech, will present our work on aptamer/ target complexes using a SPR Biacore™ T200 instrument. Examples will be described for small molecule, peptide and protein interactions with our in house-selected and optimized NOVAptamers. Dr. Ivaskovic will be available on-site for discussions. Don’t hesitate to book a slot and connect with her during the event — it’s a great opportunity to talk about NOVAptamers applications and explore how they could address your specific needs. See you there! For booking a slot with Petra and more information, feel free to contact us at contact@novaptech.com or LinkedIn.
Novaptech : nouveaux locaux !
Inauguration of the brand new premises of Novaptech, a leading biotechnology company producing aptamers for the detection of contaminants in the food industry Novaptech, an innovative biotechnology company, inaugurated its new premises in Gradignan on May 31st, 2024, in the presence of Mr Alain Rousset, President of the Conseil Régional de Nouvelle-Aquitaine. Created in 2016 from Jean-Jacques Toulmé’s academic laboratory at the University of Bordeaux, Novaptech currently has 9 employees and plans to recruit a further 5 by the end of 2025. Specialising in the development of aptamers, Novaptech stands out as the only French company to master this breakthrough technology. Aptamers, which can replace antibodies in all analytical, diagnostic and therapeutic applications, are at the heart of Novaptech’s strategy. The company is initially focusing on the development of biosensors for real-time detection of contaminants in the agri-food industry, such as pesticides, micropollutants and endocrine disruptors, in response to the need for rapid, simple and decentralised testing. In line with the objectives of the Neo Terra strategic roadmap drawn up by the Conseil Régional de Nouvelle-Aquitaine for the ecological and energy transition, Novaptech recently validated its first laboratory-scale aptasensor. The Conseil Régional de Nouvelle-Aquitaine has supported Novaptech since its creation. Once again this year, the Region has supported the company in strengthening its export strategy, particularly in Asia. The inauguration of these brand new premises marks an important step for Novaptech, consolidating its role as a leader in the biotechnology sector and its commitment to innovation and the protection of public health. For more details, read the full press release from the Cabinet of President Alain Rousset here (in French).
ECHOS parle de nous !
ECHOS is talking about us ! https://www.echos-judiciaires.com/actualites/novaptech-le-potentiel-insoupconne-des-aptameres/
FR 
EN